Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Prestige Consumer Healthcare has voluntarily recalled 39,060 bottles of Clear Eyes Maximum itchy eye relief due to "potential contamination" and a "lack of assurance of sterility." The Class II recall — meaning serious harm is unlikely — covers one lot distributed across the U.S. No adverse events have been reported. This is the third major eye drop recall in the U.S. this summer.
Prestige Consumer Healthcare has voluntarily recalled 39,060 15 mL bottles of Clear Eyes Maximum itchy eye relief after determining that one lot had a "potential for contamination" and a "lack of assurance of sterility." The affected bottles expire September 30, 2027, and were distributed nationwide before being recalled on July 29. Contamination was not confirmed, but the company acted out of caution.
The recall is classified as Class II by the FDA, meaning the probability of serious harm is remote and any adverse effects would likely be temporary or medically reversible. No adverse events or infections have been reported. Customers can reach the manufacturer via the Clear Eyes website or by calling 800-443-4908.
By the Numbers:
Why it matters: Eye care providers should use this recall as an opportunity to counsel patients — not only about the recall itself, but also about the broader risks of OTC redness-relief drops containing vasoconstrictors like naphazoline hydrochloride, which can cause rebound redness and mask underlying conditions like dry eye or allergic conjunctivitis.
